[1] 李锐,刘芳,李芸香,等. 微生物转化法制备双脱甲氧基姜黄素糖苷化产物及其对HepG2肿瘤细胞的抑制作用[J]. 食品与发酵工业,2016,42(6): 20-25.
[2] 袁鹏,陈莹,肖发,等. 姜黄素的生物活性及在食品中的应用[J]. 食品工业科技,2012,33(14):371-375.
[3] 柯秀梅,杨荣平,梁旭明. 姜黄素增溶方法的研究进展[J]. 天然产物研究与开发,2013,25(8):1 154-1 159.
[4] HASSANINASAB A,HASHIMOTO Y,TOMITA-YOKKTANI K,et al. Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism[J]. Proceedings of the National Academy of Sciences,2011,108(16):6 615-6 620.
[5] PIANPUMEPONG P,ANAL A K,DOUNGCHAWEE G,et al. Study on enhanced absorption of phenolic compounds of Lactobacillus-fermented turmeric (Curcuma longa Linn.) beverages in rats[J]. International Journal of Food Science & Technology,2012,47(11):2 380-2 387.
[6] WANG Sujuan,PENG Xixi,CUI Liangliang,et al. Synthesis of water-soluble curcumin derivatives and their inhibition on lysozyme amyloid fibrillation[J]. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy,2018,190:89-95.
[7] KIMS W,HA K C,CHOI E K,et al. The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study[J]. BMC Complementary and Alternative Medicine,2013,13(1):58-58.
[8] SLAVOMIRA D,SOUTO E B,SILVA A M. Hansen solubility parameters (HSP) for pre-screening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines[J]. Pharmaceutical Development and Technology,2018,23(1):96-105.
[9] PURPURA M,LOWERY R P,WILSON J M,et al. Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects [J]. European Journal of Nutrition,2017,57(3): 1-10.
[10] ANAND P,KUNNUMAKKARAA A B,NEWMAN R A,et al. Bioavailability of curcumin:problems and promises [J]. Mol Pharm,2007,4(6): 807-818.
[11] PURPURA M,LOWERY R P,WILSON J M,et al. Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects[J]. European Journal of Nutrition,2017,57(3):1-10.
[12] 刘彬,赵莹,于思礼,等. 微生物代谢工程发酵姜黄素研究进展[J]. 食品与发酵工业,2016,42(7): 254-260.
[13] 魏妍婷,马三梅. 姜黄素衍生物及复合物抗肿瘤的研究[J]. 生命科学,2017,29(4):386-392.
[14] 伍敏晖,王磊,何梅. 高压微射流均质对姜黄素纳米乳液稳定性的影响[J]. 中国食品学报,2018,18(5):56-62.
[15] 黄淑芳,应华洲,胡永洲. 含氮姜黄素衍生物的合成及抗肿瘤活性研究[J]. 中国药物化学杂志,2011,21(2):88-95.
[16] 陈建平,彭莞仪,秦小明,等. 姜黄素超分子包合物的结构鉴定及其抗氧化活性[J]. 食品工业科技,2017(21):28-32.
[17] SAFAVY A,RAISCH P,MANTENA S,et al. Design and development of water-soluble curcumin conjugates as potential anticancer agents[J]. Journal of Medicinal Chemistry,2007,50(24):6 284-6 288.
[18] KAMINAGA Y,NAGATSU A,AKIYAMA T,et al. Production of unnatural glucosides of curcumin with drastically enhanced water solubility by cell suspension cultures of Catharanthus roseus[J]. FEBS Letters,2003,555(2):311-316.
[19] 孟岚,吴旭日,陈依军. 糖苷合成酶及应用的研究进展[J]. 广西科学,2017,24(1):7-14.
[20] CHOUDHURY A K,RAJA S,MAHAPATRA S,et al. Synthesis and evaluation of the anti-oxidant capacity of curcumin glucuronides,the major curcumin metabolites [J]. Antioxidants,2015,4(4): 750-767.
[21] ZHANG Xing,LI Min,LI Rui,et al. Microbial transformation of curcumin by Rhizopus chinensis [J]. Biocatalysis,2015,28(5-6): 380-386.
[22] PRASAD E,HAMEEDA B,RAO A B,et al. Biotransformation of curcumin for improved biological activity and antiproliferative activity on acute HT-29 human cell lines [J]. Indian Journal of Biotechnology,2014,13(3): 324-329.
[23] 姚瑶,霍元鹏,周伟,等. 高产β-葡萄糖苷酶菌株的筛选及产酶条件优化[J]. 江西农业学报,2018,30(3):97-101.
[24] PATIDAR P,PILLAI S A,SHETH U,et al. Glucose triggered enhanced solubilisation,release and cytotoxicity of poorly water soluble anti-cancer drugs fromT1307 micelles[J]. Journal of Biotechnology,2017,254:43-50.
[25] HOLDER G M,PLUMMER J L,RYAN A J. The metabolism and excretion of curcumin (1,7-Bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat [J]. Xenobiotica,1978,8(12): 761-768.
[26] ZENG Jia,YANG Nan,LI Xiumin,et al. 4′-O-methylglycosylation of curcumin by Beauveria bassiana [J]. Natural Product Communications,2010,5(1): 77-80.